Innate immunity defects in Hermansky-Pudlak type 2 syndrome

Blood

Volumn 107, Issue 12, 2006, Pages 4857-4864

  Fontana, Stefania ^b   Parolini, Silvia ^b   Vermi, William ^b   Booth, Sarah ^b   Gallo, Federico ^b   Donini, Marta ^b   Benassi, Marzia ^b   Gentili, Francesca ^b   Ferrari, Daniela ^b   Notarangelo, Lucia D ^b   Cavadini, Patrizia ^b   Marcenaro, Emanuela ^b   Dusi, Stefano ^b   Cassatella, Marco ^b   Facchetti, Fabio ^b   Griffiths, Gillian M ^b   Moretta, Alessandro ^b   Notarangelo, Luigi D ^b   Badolato, Raffaele ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD36 ANTIGEN; ELASTASE; PERFORIN;

ALBINISM; ANTIGEN EXPRESSION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLEEDING TENDENCY; CASE REPORT; CHILD; CYTOLYSIS; FEMALE; GENE MUTATION; HERMANSKY PUDLAK SYNDROME TYPE 2; HUMAN; IMMUNE DEFICIENCY; IMMUNOBLOTTING; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; SIBLING;

EID: 33745083115     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-4398     Document Type: Article

References (41)

1. Clark RH, Stinchcombe JC, Day A, et al. Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse. Nat Immunol. 2003;4:1111-1120.
2. Dell'Angelica EC, Ohno H, Ooi CE, et al. AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J. 1997;16:917-928.
3. Odorizzi G, Cowles CR, Emr SD. The AP-3 complex: a coat of many colours. Trends Cell Biol. 1998;8:282-288.
4. Robinson MS. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004;14:167-174.
5. Peden AA, Oorschot V, Hesser BA, et al. Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins. J Cell Biol. 2004;164:1065-1076.
6. Nakatsu F, Ohno H. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct. 2003;28:419-429.
7. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 2003;72:395-447.
8. Clark R, Griffiths GM. Lytic granules, secretory lysosomes and disease. Curr Opin Immunol. 2003;15:516-521.
9. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999;3:11-21.
10. Yang W, Li C, Ward DM, Kaplan J, Mansour SL. Defective organellar membrane protein trafficking in Ap3b1-deficient cells. J Cell Sci. 2000;113(pt 22):4077-4086.
11. Sugita M, Cao X, Watts GF, et al. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity. 2002;16:697-706.
12. Cernadas M, Sugita M, van der WN, et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J Immunol. 2003;171:4149-4155.
13. Shotelersuk V, Dell'Angelica EC, Hartnell L, Bonifacino JS, Gahl WA. A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med. 2000;108:423-427.
14. Huizing M, Gahl WA. Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med. 2002;2:451-467.
15. Huizing M, Scher CD, Strovel E, et al. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2. Pediatr Res. 2002;51:150-158.
16. Feng L, Novak EK, Hartnell LM, et al. The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes. Blood. 2002;99:1651-1658.
17. Fujita H, Sasano E, Yasunaga K, et al. Evidence for distinct membrane traffic pathways to melanosomes and lysosomes in melanocytes. J Investig Dermatol Symp Proc. 2001;6:19-24.
18. Richmond B, Huizing M, Knapp J, et al. Melanocytes derived from patients with Hermansky-Pudlak syndrome types 1, 2, and 3 have distinct defects in cargo trafficking. J Invest Dermatol. 2005;124:420-427.
19. Starcevic M, Nazarian R, Dell'Angelica EC. The molecular machinery for the biogenesis of lysosome-related organelles: lessons from Hermansky-Pudlak syndrome. Semin Cell Dev Biol. 2002;13:271-278.
20. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet. 2003;35:90-96.
21. Windhorst DB, Zelickson AS, Good RA. Chediak-Higashi syndrome: hereditary gigantism of cytoplasmic organelles. Science. 1966;151:81-83.
22. Blume RS, Bennett JM, Yankee RA, Wolff SM. Defective granulocyte regulation in the Chediak-Higashi syndrome. N Engl J Med. 1968;279:1009-1015.
23. Griscelli C, Durandy A, Guy-Grand D, et al. A syndrome associating partial albinism and immunodeficiency. Am J Med. 1978;65:691-702.
24. Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000;343:1703-1714.
25. Katz P, Zaytoun AM, Fauci AS. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay. J Clin Invest. 1982;69:1231-1238.
26. Perez N, Virelizier JL, Arenzana-Seisdedos F, Fischer A, Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr. 1984;104:569-573.
27. Plebani A, Ciravegna B, Ponte M, Mingari MC, Moretta L. Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome. Eur J Pediatr. 2000;159:713-714.
28. Gulino AV, Moratto D, Sozzani S, et al. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood. 2004;104:444-452.
29. Vulcano M, Dusi S, Lissandrini D, et al. Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J Immunol. 2004;173:5749-5756.
30. Parolini S, Bottino C, Falco M, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med. 2000;192:337-346.
31. Moretta A, Vitale M, Bottino C, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 1993;178:597-604.
32. Peden AA, Rudge RE, Lui WW, Robinson MS. Assembly and function of AP-3 complexes in cells expressing mutant subunits. J Cell Biol. 2002;156:327-336.
33. Witko-Sarsat V, Cramer EM, Hieblot C, et al. Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood. 1999;94:2487-2496.
34. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197-223.
35. Vitale M, Della Chiesa M, Carlomagno S, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005;106:566-571.
36. Stinchcombe J, Bossi G, Griffiths GM. Linking albinism and immunity: the secrets of secretory lysosomes. Science. 2004;305:55-59.
37. Rous BA, Reaves BJ, Ihrke G, et al. Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes. Mol Biol Cell. 2002;13:1071-1082.
38. Shanahan F, Randolph L, King R, et al. Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases. Am J Med. 1988;85:823-828.
39. Berz F, Weiss M, Belohradsky BH. Albinism, thrombopathy, ceroid storage disease - Hermansky-Pudlak syndrome. Overview and description with immunodeficiency [in German]. Klin Padiatr. 1996;208:83-87.
40. Sivori S, Pende D, Bottino C, et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 1999;29:1656-1666.
41. Boehm M, Bonifacino JS. Genetic analyses of adaptin function from yeast to mammals. Gene. 2002;286:175-186.